Skip to content

Alphatec Holdings ATEC Inventory write-downs

Inventory write-downs at other companies

Globus Medical logo
Globus MedicalGMED
$4.96M-16.8%
Establishment Labs logo
Establishment LabsESTA
$1.3M+100%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$761K+19.5%
Novanta logo
NovantaNOVT
$710K-6.2%

Other financials

Income statement

See full
Revenue$192.1M+13.6%
Gross profit$136.5M+17.7%
Operating income-$22.6M+49.0%
Net income-$33.9M+34.7%
EPS (diluted)-$0.22+37.1%

Balance sheet

See full
Cash & equivalents$139.9M-8.7%
Total debt$603.1M+3.7%
Total equity-$5.3M+93.8%
Total assets$799.5M+1.8%

Cash flow

See full
Operating cash flow$1.3M+126%
CapEx$12.1M+21.7%
Free cash flow-$10.8M+27.9%

Valuation

See full
Market cap$1.34B-16.3%
Enterprise value$1.8B-11.2%
P/S1.7×-0.8×

Profitability

See full
Gross margin70.2%+1.2pp
Operating margin-7.7%-3.0pp
Net margin-15.9%-4.4pp
FCF margin-12.7%-5.1pp

Returns & leverage

See full
Return on equity-812.1%
Debt / equity48×
Current ratio1.9×-0.9×

Where this comes from

Reported directly by Alphatec Holdings in its filing.

Tagged under the XBRL concept us-gaap:InventoryWriteDown.

The official record: Alphatec Holdings’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alphatec Holdings's inventory write-downs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alphatec Holdings's inventory write-downs?
Alphatec Holdings (ATEC) reported inventory write-downs of $3.62M in Q1 2026.
How has Alphatec Holdings's inventory write-downs changed year-over-year?
Alphatec Holdings's inventory write-downs increased by 1.3% year-over-year, from $3.57M to $3.62M.
What is the long-term trend for Alphatec Holdings's inventory write-downs?
Over 4 years (2021 to 2025), Alphatec Holdings's inventory write-downs has grown at a 5.0% compound annual growth rate (CAGR), from $11.15M to $13.54M.
What does inventory write-downs mean?
Represents the reduction in the carrying value of inventory due to obsolescence, damage, or market price declines. This metric signals potential inefficiencies in supply chain management or product lifecycle planning within the medical device portfolio.